Article content
The European Medicines Agency’s (EMA) leading vaccine expert said that data on COVID-19 vaccines tailored for the Omicron variant should be available between April and July this year, potentially paving the way for a decision by the summer.
Vaccine makers such as Moderna and Pfizer have begun testing COVID-19 vaccines designed to target the Omicron coronavirus variant. (Reporting by Manas Mishra and Ludwig Burger Editing by David Goodman)
financialpost.com